Key Laboratory of Animal Diseases Diagnostic and Immunology, Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agriculture University, Nanjing 210095, Jiangsu, China.
Vet J. 2012 Jun;192(3):385-9. doi: 10.1016/j.tvjl.2011.08.005. Epub 2011 Oct 19.
The immunogenicity of a putative N-linked glycosylation site located at amino acids 143-145 (N143YS) of the porcine circovirus 2 (PCV2) Cap protein was investigated. Eukaryotic vectors expressing wild-type PCV2 Cap (pCap) and N-linked glycosylation site mutant Cap (pCap-m) were constructed and the immunogenicity of these proteins was determined following DNA vaccination in BALB/c mice. pCap-m elicited significantly higher Cap-specific T lymphocyte proliferative activity, percentage of CD8(+) T cells, ratio of immunoglobulin (Ig) G2a:IgG1 and levels of interferon-γ compared to pCap (P<0.05). These results indicate that deletion of the N-glycosylation site in the PCV2 Cap protein enhances specific immune responses and may have a role in Cap-based DNA vaccines with enhanced immunogenicity.
本研究旨在探究位于猪圆环病毒 2(PCV2)衣壳蛋白氨基酸 143-145 处(N143YS)的一个假定 N 连接糖基化位点的免疫原性。构建了表达野生型 PCV2 衣壳蛋白(pCap)和 N 连接糖基化位点突变衣壳蛋白(pCap-m)的真核载体,并在 BALB/c 小鼠中进行 DNA 疫苗接种后,测定这些蛋白的免疫原性。与 pCap 相比,pCap-m 诱导的 Cap 特异性 T 淋巴细胞增殖活性、CD8(+)T 细胞百分比、IgG2a:IgG1 比值和干扰素-γ水平显著更高(P<0.05)。这些结果表明,PCV2 衣壳蛋白中 N 糖基化位点的缺失增强了特异性免疫反应,并且可能在增强免疫原性的基于 Cap 的 DNA 疫苗中发挥作用。